Kyolic Formula 103
Natural health product licensed in Canada
- Licence holder
- Wakunaga of America Co., Ltd.
- NPN or DIN-HM
- 80058351
- Status
- Active licence
- Licence date
- 20 February 2015
- Revision date
- 3 March 2017
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 236.8 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zinc Source : Produit de chélation de zinc et de protéine végétale hydrolysée (PVH) | 0.7 milligramme | 2,800 µg |
| Allium sativum Source : Allium sativum - Bulbe Extract : Matériel brut sec Extraction ratio : 3:1 Dry plant equivalent : 660 milligramme | 220 milligramme | Not calculated |
| Wolfiporia extensa Source : Corps fructifère | 13.5 milligramme | Not calculated |
| Wolfiporia extensa Source : Wolfiporia extensa | 13.5 milligramme | Not calculated |
| Ganoderma lucidum Source : Ganoderma lucidum (fruiting body) | 13.5 milligramme | Not calculated |
| Agaricus blazei Source : Agaricus blazei - Fruiting body | 7.5 milligramme | Not calculated |
| Astragalus membranaceus Source : Astragalus membranaceus - racine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 250 milligramme | 50 milligramme | Not calculated |
| Grifola frondosa Source : Grifola frondosa - Fruiting body | 13.5 milligramme | Not calculated |
| Lentinula edodes Source : Lentinula edodes - fruiting body | 27 milligramme | Not calculated |
| Olea europaea Source : Olea europaea - feuille Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 400 milligramme Potency : 18 % Oleuropein | 40 milligramme | Not calculated |
| Vitamine C Source : Ascorbate de calcium | 59.2 milligramme | 236,800 µg |
| Origanum vulgare Source : Origanum vulgare - feuille Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 200 milligramme | 50 milligramme | Not calculated |
Non-medicinal ingredients
Gélatine, Stéarate de magnésium, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 2 days |
Uses authorised in Canada
Helps maintain immune function and an antioxidant for the maintenance of good health. Provides antioxidants. Source of fungal polysaccharides with immunomodulating properties.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity (e.g. allergy) has been known to occur; in which case discontinue use. Dizziness, irritated skin, nausea and diarrhea have been known to occur; in which case, discontinue use. Allergic reactions can occur in people allergic to plants of the Oleacea family.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding, if you have diabetes or a kidney disorder or if you have an auto-immune disorder. Consult a health care practitioner prior to use if you are taking other diuretics, or if you are taking blood thinners or protease inhibitors. If you suffer from an immune system disorder (e.g. Crohn's disease, myasthenia gravis, multiple sclerosis, rheumatoid arthritis, lupus, HIV/AIDS, etc.) or if you are taking immunosuppressants, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80058351
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2017. Photograph the packaging to check whether it has changed. Photograph the packaging